Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Bay Area biotech company Tempest Therapeutics was once valued at more than $1 billion, but now it's running out of gas. Last week, the cancer researcher revealed plans to lay off all but five of its ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Vivo Capital announced multiple legal proceedings to challenge the “irresponsible actions” taken by the current board of Directors of Sinovac ...

BENGALURU: Union Minister of State for Science and Technology and Earth Sciences Jitendra Singh on Thursday emphasised the ...